Number of federal Invokana lawsuits jumps from December to January

Jan. 18, 2017 – San Diego, CA — The number of Invokana lawsuits has been climbing steadily since the Judicial Panel on Multidistrict Litigation (JPML) consolidated federal cases in New Jersey last month.

There were 63 Invokana cases filed as part of the multidistrict litigation (MDL) in December, according to an MDL Statistics Report released by the JPML on Dec. 15.

That number jumped to 100 this month, according to a new report updated Jan. 17.

Attorneys and the New Jersey federal court alike believe the number of Invokana cases is expected to continue rising.

“There are currently hundreds of potential cases comprising this multidistrict litigation, as well as cases venued throughout the country,” wrote U.S. District Judge Brian Martinotti in the first Case Management Order issued Jan. 12.

Indeed, hundreds of people have been injured as a result of taking the type II diabetes medication Invokana.

The U.S. Food and Drug Administration (FDA) received 101 reports of serious kidney injury alone in the two years after Invokana was approved. This prompted the administration to strengthen warnings on the Invokana label related to the risk of acute kidney injury in June 2016.

The diabetes drug has been associated with many other serious adverse reactions, including heart attack, stroke, respiratory failure, and a condition that causes too much acid to build up in the blood called diabetic ketoacidosis.

At least two of the patients whose cases were reported to the FDA died of heart attacks after being hospitalized for acute kidney disease. Two other patients also died in the hospital, but not of heart attacks.

Invokana lawsuits are sometimes brought to court on behalf of loved ones who died as a result of taking the diabetes drug.

A widowed Texas woman recently filed an Invokana lawsuit on behalf of her late husband, who died of a heart attack after taking Invokana.

Cynthia Freeman filed a lawsuit on behalf of herself and her late husband Kenneth on Dec. 27 against Janssen Pharmaceuticals Inc., the company that markets Invokana in the United States. Janssen is a subsidiary of pharmaceutical giant Johnson & Johnson.

The lawsuit accuses Janssen of concealing and continuing to conceal its knowledge of Invokana’s “unreasonably dangerous” risks and asserts claims for 10 counts. Those counts include failure to warn about the drug’s risks, negligence, and fraud, among others.

Cynthia’s case was one of several transferred from federal courts across the country to the newly formed MDL in New Jersey. Hundreds more are expected to be filed in the future.

Invokana & Invokamet Lawsuits

If you or someone you love was injured as a result of taking Invokana or its sister drug Invokamet, you may be entitled to a large cash settlement.

Hood National Law Group is now accepting cases involving patients who took Invokana or Invokamet and developed diabetic ketoacidosis, kidney failure, and other injuries. If you were harmed by either of these medications, call us today at 1-800-214-1010 for a free case evaluation or use the form on the right-hand side of your screen.